Thürlimann, B.; Beretta, K.; Bacchi, M.; Castiglione-Gertsch, M.; Goldhirsch, A.; Jungi, W. F.; Cavalli, F.; Senn, H.-J.; Fey, M.; Löhnert, T. (1996). First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Annals of oncology, 7(5), pp. 471-479. Oxford University Press 10.1093/oxfordjournals.annonc.a010635
|
Text
7-5-471.pdf - Published Version Available under License Publisher holds Copyright. Download (4MB) | Preview |
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Castiglione, Monica, Fey, Martin |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0923-7534 |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Markus Müller |
Date Deposited: |
27 Sep 2018 14:21 |
Last Modified: |
05 Dec 2022 15:13 |
Publisher DOI: |
10.1093/oxfordjournals.annonc.a010635 |
BORIS DOI: |
10.7892/boris.115807 |
URI: |
https://boris.unibe.ch/id/eprint/115807 |
Actions (login required)
 |
Edit item |